JABET
SearchSign In/UpSubmit Manuscript
Home
Special IssuesEditorial BoardAnnouncements
RSS Feed
Original article| Open access | J Adv Biotechnol Exp Ther. 2025; 8(1): 64-78|doi: 10.5455/jabet.2025.06

Genomic insights into multidrug-resistant Acinetobacter baumannii strains isolated from Dhaka, Bangladesh

Abstract

Acinetobacter baumannii is one of the most common nosocomial infections causing pathogens. Multidrug-resistant (MDR) A. baumannii is a growing concern to the healthcare system in Bangladesh, necessitating the elucidation of the genetic characteristics of this species. Five MDR, biofilm-forming A. baumannii strains isolated from clinical samples in Dhaka, Bangladesh, underwent a comprehensive whole-genome shotgun sequencing. In silico analyses determined strain types, antibiotic resistance, and virulence genes. The phylogenomic and pan-genome comparative analysis included the study samples along with an additional 15 Bangladeshi A. baumannii strains collected from the public database. The antibiotic-resistant profile showed that all the strains were resistant to meropenem. Two strains were resistant to polymyxin B up to 64 µg/ml. The average draft genome size of the strains was 3.93 Mbp, with about 39% GC content. Multilocus sequence typing characterized the strains as ST1, ST2, ST164, and ST623. All strains carried different classes of β-lactamase genes, including the carbapenem hydrolyzing enzyme coding genes blaoxa-23 and blaoxa-51. One of the five strains studied harbored blaNDM-9 and blaNDM-23 genes. The phosphotransferase group of aminoglycosides modifying enzymes was the most common. All the strains had relatively similar virulence profiles. Pan-genome analysis revealed 1944 core and 1302 unique genes. Phylogenomic analysis revealed the distribution of these strains in different clusters with other MDR strains isolated worldwide. The study results suggest the implementation of antibiotic stewardship and genomic surveillance of MDR A. baumannii to control the spread of antibiotic resistance in Bangladesh.

Keywords

References

  • [1]Murray CJ, Ikuta KS, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet (London, England). 2022;399:629–55.
  • [2]Manyi-Loh C, Mamphweli S, et al. Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. Molecules. 2018;23.
  • [3]Runa N, Yesmin S, et al. Prevalence of multidrug-resistant ESBL-producing Escherichia coli isolated from beef and sheep meat in Sylhet, Bangladesh. J Adv Biotechnol Exp Ther. 2024;7:520.
  • [4]Nusrat T, Akter N, et al. Antibiotic resistance and sensitivity pattern of Metallo-β-Lactamase Producing Gram-Negative Bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh. Hosp Pract. 2020:1–9.
  • [5]Lee CR, Lee JH, et al. Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7.
  • [6]Hasan MJ, Rabbani R. The need for adequate research data on carbapenem use and resistance in Bangladesh. Lancet Infect Dis. 2019;19.
  • [7]Mia MF, Khan AA, et al. Health Care Associated Multidrug Resistant Acinetobacter Infections in a Tertiary Critical Care Center of Dhaka, Bangladesh. J Bangladesh Coll Physicians Surg. 2020;38:59–63.
  • [8]Afroz J, Jubyda FT, et al. Multidrug resistant clinical strains isolated from tracheal aspirates of patients in Dhaka, Bangladesh. Int J Res Med Sci. 2020;8:1094.
  • [9]Afroz H, Fakruddin M, et al. Incidence of and risk factors for hospital acquired infection in a tertiary care hospital of Dhaka, Bangladesh. Bangladesh J Med Sci. 2017;16.
  • [10]Khan MAS, Chaity SC, et al. Genomic epidemiology of multidrug-resistant clinical Acinetobacter baumannii in Bangladesh. Infect Genet Evol. 2024;123:105656.
  • [11]Johnson JS, Spakowicz DJ, et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun. 2019;10:1–11.
  • [12]CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. CLSI supplement M100. Informational Supplement M100-S31. vol. 8. 2021.
  • [13]CDC, DGHS. Standard Treatment Guidelines (STG) on Antibiotic Use in Common Infectious Diseases of Bangladesh. Commun Dis Control Dir Gen Heal Serv. 2021;1:1–170.
  • [14]Magiorakos AP, Srinivasan A, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.
  • [15]Zhang H, Yu F, et al. Rapid Detection of MCR-Mediated Colistin Resistance in Escherichia coli. Microbiol Spectr. 2022;10.
  • [16]Mendoza-Olazarán S, Camacho-Ortiz A, et al. Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates. Am J Infect Control. 2014;42:874–8.
  • [17]Stepanović S, Vuković D, et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40:175–9.
  • [18]Ullah MA, Islam MS, et al. Assessment of prevalence, antibiotic resistance, and virulence profiles of biofilm-forming Enterococcus faecalis isolated from raw seafood in Bangladesh. Heliyon. 2024;10.
  • [19]Tabassum J, Anjum A, et al. Draft genome sequencing data of multidrug-resistant Staphylococcus haemolyticus from Bangladeshi hospitals. Data Br. 2024:110918.
  • [20]Olson RD, Assaf R, et al. Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): a resource combining PATRIC, IRD and ViPR. Nucleic Acids Res. 2023;51:D678–89.
  • [21]Wick RR, Judd LM, et al. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13:e1005595.
  • [22]Bankevich A, Nurk S, et al. SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19.
  • [23]Wick RR, Schultz MB, et al. Bandage: Interactive visualization of de novo genome assemblies. Bioinformatics. 2015;31.
  • [24]Gurevich A, Saveliev V, et al. QUAST: Quality assessment tool for genome assemblies. Bioinformatics. 2013;29:1072–5.
  • [25]Li H, Handsaker B, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–9.
  • [26]Li W, O’Neill KR, et al. RefSeq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation. Nucleic Acids Res. 2021;49:D1020–8.
  • [27]Grant JR, Enns E, et al. Proksee: In-depth characterization and visualization of bacterial genomes. Nucleic Acids Res. 2023;51:W484–92.
  • [28]Alcock BP, Huynh W, et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res. 2023;51:D690–9.
  • [29]Rahman A, Styczynski A, et al. Genomic landscape of prominent XDR Acinetobacter clonal complexes from Dhaka, Bangladesh. BMC Genomics. 2022;23:1–16.
  • [30]Jahan MI, Rahaman MM, et al. Draft genome sequence of a carbapenem-resistant clinical Acinetobacter baumannii revealing co-existence of four classes of β-lactamases. J Glob Antimicrob Resist. 2021;27:329–31.
  • [31]Diancourt L, Passet V, et al. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 2010;5.
  • [32]Larsen M V, Cosentino S, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50:1355–61.
  • [33]Siguier P, Perochon J, et al. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34.
  • [34]Arndt D, Grant JR, et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res. 2016;44:W16–21.
  • [35]Cosentino S, Voldby Larsen M, et al. PathogenFinder - Distinguishing Friend from Foe Using Bacterial Whole Genome Sequence Data. PLoS One. 2013;8:e77302.
  • [36]Bertelli C, Laird MR, et al. IslandViewer 4: expanded prediction of genomic islands for larger-scale datasets. Nucleic Acids Res. 2017;45:W30–5.
  • [37]Chaudhari NM, Gupta VK, et al. BPGA- an ultra-fast pan-genome analysis pipeline. Sci Rep. 2016;6:24373.
  • [38]Jain C, Rodriguez-R LM, et al. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat Commun 2018 91. 2018;9:1–8.
  • [39]Meier-Kolthoff JP, Göker M. TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy. Nat Commun. 2019;10:2182.
  • [40]Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49:W293–6.
  • [41]Bosi E, Fani R, et al. Defining orthologs and pangenome size metrics. Methods Mol Biol. 2015;1231:191–202.
  • [42]Hasan J, Hosen S, et al. The resistance growing trend of common gramnegative bacteria to the potential antibiotics over three consecutive years: a single center experience in Bangladesh. Pharm Pharmacol Int J. 2019;7.
  • [43]Liu H, Moran RA, et al. Longitudinal genomics reveals carbapenem-resistant Acinetobacter baumannii population changes with emergence of highly resistant ST164 clone. Nat Commun. 2024;15:9483.
  • [44]Sakuma M, Tohya M, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from a hospital in Nepal. J Glob Antimicrob Resist. 2024;38:363–7.
  • [45]Liang J, Zhou K, et al. Identification and Characterization of a Novel Aminoglycoside 3’’-Nucleotidyltransferase, ANT(3’’)-IId, From Acinetobacter lwoffii. Front Microbiol. 2021;12:2487.
  • [46]Tahbaz S V., Azimi L, et al. Characterization of aminoglycoside resistance mechanisms in Acinetobacter baumannii isolates from burn wound colonization. Ann Burns Fire Disasters. 2019;32:115.
  • [47]Nie L, Lv Y, et al. Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China. Acta Pharm Sin B. 2014;4:295–300.
  • [48]Biondi S, Long S, et al. Current trends in beta-lactam based beta-lactamases inhibitors. Curr Med Chem. 2011;18.
  • [49]Rumbo C, Gato E, et al. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57:5247–57.
  • [50]Lopes BS, Amyes SGB. Insertion sequence disruption of adeR and ciprofloxacin resistance caused by efflux pumps and gyrA and parC mutations in Acinetobacter baumannii. Int J Antimicrob Agents. 2013;41:117–21.
  • [51]Park YK, Choi JY, et al. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 2011;37:525–30.
  • [52]Gerson S, Lucaßen K, et al. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii. Int J Antimicrob Agents. 2020;55.
  • [53]Hornsey M, Ellington MJ, et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother. 2010;65:1589–93.
  • [54]Richmond GE, Evans LP, et al. The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner. MBio. 2016;7.
  • [55]Atasoy AR, Ciftci IH, et al. Investigation of mutations in adeR and adeS gene regions in gentamicine resistant Acinetobacter baumannii isolates. Biotechnol Biotechnol Equip. 2016;30:360–7.
  • [56]Greene C, Wu J, et al. Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces. Lett Appl Microbiol. 2016;63:233–9.
  • [57]Zeighami H, Valadkhani F, et al. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect Dis. 2019;19:1–9.
  • [58]Gedefie A, Demsis W, et al. Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review. Infect Drug Resist. 2021;14:3711.
  • [59]Karah N, Mateo-Estrada V, et al. The Acinetobacter baumannii website (Ab-web): a multidisciplinary knowledge hub, communication platform, and workspace. FEMS Microbes. 2023;4:1–4.
  • [60]Gaillot S, Oueslati S, et al. Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9. Front Microbiol. 2023;14:1–11.
  • [61]García-González N, Beamud B, et al. Tracking the Emergence and Dissemination of a bla NDM-23 Gene in a Multidrug Resistance Plasmid of Klebsiella pneumoniae . Microbiol Spectr. 2023;11.

Article Info

Academic Editor

Md. Masudur Rahman, PhD; Obihiro University, Japan
Received
13 September, 2024
Accepted
20 November, 2024
Published
11 December, 2024
Article DOI:10.5455/jabet.2025.06

Coresponding author

Sohidul Islam, Department of Biochemistry & Microbiology, North South University, Dhaka, Bangladesh, Email: sohidul.islam@northsouth.edu

Cite this article

Ferdous S, Shayer KMSA, et al., Genomic insights into multidrug-resistant Acinetobacter baumannii strains isolated from Dhaka, Bangladesh. J Adv Biotechnol Exp Ther. 2025 Jan; 8(1): 64-78.

Related Articles

Occurrence of multi-antibiotic resistant bacteria isolated from food handlers’ hands and utensils at different restaurants in Dhaka, Bangladesh
Determination of multi-drug resistance profile of isolated Gram-positive and Gram-negative bacteria from clinical pus samples in Bangladesh
Identification of polymorphisms in melanocortin 1 receptor gene and their association with coat color variants in Black Bengal goat
Analysis of β-casein gene for A1 and A2 allelic variants in Holstein-Local crossbred cattle of Bangladesh using allele-specific PCR
Genomic identification and characterization of prophages associated with Citrobacter freundii strains